BIBDX | CAXIX | BIBDX / CAXIX | |
Total Expense Ratio | 0.80 | 0.96 | 83% |
Annual Report Gross Expense Ratio | 0.80 | 1.35 | 59% |
Fund Existence | 17 years | 11 years | - |
Gain YTD | -7.615 | -2.728 | 279% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 2500 | 80,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 908M | 69.3M | 1,310% |
Annual Yield % from dividends | 1.55 | 3.56 | 43% |
Returns for 1 year | -7.57 | -3.41 | 222% |
Returns for 3 years | -4.79 | -3.07 | 156% |
Returns for 5 years | 21.54 | 59.15 | 36% |
Returns for 10 years | 12.58 | 52.73 | 24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSEAX | 35.14 | -1.63 | -4.43% |
JPMorgan Small Cap Equity A | |||
ETNHX | 27.33 | -1.51 | -5.24% |
Eventide Healthcare & Life Sciences N | |||
GGIDX | 12.28 | -0.72 | -5.54% |
Goldman Sachs Global Infras Instl | |||
FCNTX | 18.16 | -1.08 | -5.61% |
Fidelity Contrafund | |||
ADCYX | 18.51 | -1.14 | -5.80% |
American Century Disciplined Growth Y |